Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Educational approach and tacrolimus once-daily switch to improve adherence in transplant recipients
2011-001995-20Phase 4Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Apr 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in liver transplant and kidney transplant (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Compliance to medical prescriptions. Started Apr 2012; status: terminated.
02
Drugs
tacrolimus
03
Conditions
liver transplantkidney transplant
Beyond the preview
Go deeper on 2011-001995-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001995-20.